Mark Kessel
CIK 1222013 · View on SEC EDGAR ↗
Insider
First SEC filing: Aug. 28, 2017 · Latest: Aug. 28, 2017
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 18 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 5, 2019 | VIVS | A | 52,000 | — | — | 52,000 Direct | — | Acquired | (price as of 2026-08-20) |
| July 26, 2018 | VIVS | A | 45,500 | — | — | 45,550 Direct | +91000.00% | Acquired | (price as of 2026-08-20) |
| Aug. 24, 2017 | VIVS | A | 42,500 | — | — | 42,500 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 17, 2016 | VIVS | A | 7,500 | — | — | 15,000 Direct | +100.00% | Acquired | (price as of 2026-08-20) |
| Aug. 17, 2016 | VIVS | A | 18,500 | — | — | 18,500 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 17, 2016 | VIVS | A | 18,500 | — | — | 18,500 Direct | — | Acquired | (price as of 2026-08-20) |
| Aug. 17, 2016 | VIVS | A | 7,500 | — | — | 7,500 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 2, 2006 | AGEN | A | 3,754 | $1.73 | $6,494 | 85,630 Direct | +4.58% | Acquired | -96.1% (price as of 2026-08-20) |
| July 3, 2006 | AGEN | A | 3,065 | $2.12 | $6,498 | 81,875 Direct | +3.89% | Acquired | -96.8% (price as of 2026-08-20) |
| June 15, 2006 | AGEN | A | 15,000 | $2.02 | $30,300 | 78,810 Direct | +23.51% | Acquired | -96.7% (price as of 2026-08-20) |
| April 3, 2006 | AGEN | A | 1,230 | $5.28 | $6,494 | 63,810 Direct | +1.97% | Acquired | -98.7% (price as of 2026-08-20) |
| Jan. 13, 2006 | AGEN | A | 1,253 | $5.19 | $6,503 | 62,580 Direct | +2.04% | Acquired | -98.7% (price as of 2026-08-20) |
| Oct. 13, 2005 | AGEN | A | 1,150 | $5.65 | $6,498 | 61,327 Direct | +1.91% | Acquired | -98.8% (price as of 2026-08-20) |
| July 14, 2005 | AGEN | A | 983 | $6.61 | $6,498 | 60,177 Direct | +1.66% | Acquired | -99.0% (price as of 2026-08-20) |
| June 2, 2005 | AGEN | A | 15,000 | $6.60 | $99,000 | 58,360 Direct | +34.59% | Acquired | -99.0% (price as of 2026-08-20) |
| April 8, 2005 | AGEN | A | 834 | $7.79 | $6,497 | 44,194 Direct | +1.92% | Acquired | -99.1% (price as of 2026-08-20) |
| Jan. 14, 2005 | AGEN | A | 3,360 | $8.63 | $28,997 | 43,360 Direct | +8.40% | Acquired | -99.2% (price as of 2026-08-20) |
| May 27, 2004 | AGEN | A | 22,800 | $8.41 | $191,748 | 40,000 Direct | +132.56% | Acquired | -99.2% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 5, 2019 | VIVS | Stock Option (Right to Buy) | Common Stock (52,000) | $0.27 | Sept. 5, 2029 | 52,000 | Acquired |
| July 26, 2018 | VIVS | Stock Option (Right to Buy) | Common Stock (45,550) | $1.29 | July 26, 2028 | 45,500 | Acquired |
| Aug. 24, 2017 | VIVS | Stock Option (Right to Buy) | Common Stock (42,500) | $1.97 | Aug. 24, 2027 | 42,500 | Acquired |
| Aug. 17, 2016 | VIVS | Stock Option (Right to Buy) [F1] | Common Stock (18,500) | $4.35 | Aug. 17, 2025 | 18,500 | Acquired |
| Aug. 17, 2016 | VIVS | Stock Option (Right to Buy) [F3] | Common Stock (18,500) | $4.35 | Aug. 17, 2025 | 18,500 | Acquired |
| Oct. 2, 2006 | AGEN | Deferred Shares [F1] | Common Stock (3,754) | — | — | 3,754 | Acquired |
| July 3, 2006 | AGEN | Deferred Shares [F1] | Common Stock (3,065) | — | — | 3,065 | Acquired |
| June 15, 2006 | AGEN | Stock Option (right to buy) | Common Stock (15,000) | $2.02 | June 15, 2016 | 15,000 | Acquired |
| April 3, 2006 | AGEN | Deferred Shares [F1] | Common Stock (1,230) | — | — | 1,230 | Acquired |
| Jan. 13, 2006 | AGEN | Deferred Shares [F1] | Common Stock (1,253) | — | — | 1,253 | Acquired |
| Oct. 13, 2005 | AGEN | Deferred Shares [F1] | Common Stock (1,150) | — | — | 1,150 | Acquired |
| July 14, 2005 | AGEN | Deferred Shares [F1] | Common Stock | — | — | 983 | Acquired |
| June 2, 2005 | AGEN | Stock Option (right to buy) | Common Stock (15,000) | $6.60 | June 2, 2015 | 15,000 | Acquired |
| April 8, 2005 | AGEN | Deferred Shares [F1] | Common Stock | — | — | 834 | Acquired |
| Jan. 14, 2005 | AGEN | Deferred Shares [F1] | Common Shares (3,360) | — | — | 3,360 | Acquired |
| May 27, 2004 | AGEN | Stock Option (right to buy) | Common Stock (22,800) | $8.41 | May 27, 2014 | 22,800 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).